A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
- 19 September 1986
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 233 (4770), 1318-1321
- https://doi.org/10.1126/science.3489291
Abstract
The adoptive transfer of tumor-infiltrating lymphocytes (TIL) expanded in interleukin-2 (IL-2) to mice bearing micrometastases from various types of tumors showed that TIL are 50 to 100 times more effective in their therapeutic potency than are lymphokine-activated killer (LAK) cells. Therefore the use of TIL was explored for the treatment of mice with large pulmonary and hepatic metastatic tumors that do not respond to LAK cell therapy. Although treatment of animals with TIL alone or cyclophosphamide alone had little impact, these two modalities together mediated the elimination of large metastatic cancer deposits in the liver and lung. The combination of TIL and cyclophosphamide was further potentiated by the simultaneous administration of IL-2. With the combination of cyclophosphamide, TIL, and IL-2, 100% of mice (n = 12) bearing the MC-38 colon adenocarcinoma were cured of advanced hepatic metastases, and up to 50% of mice were cured of advanced pulmonary metastases. Techniques have been developed to isolate TIL from human tumors. These experiments provide a rationale for the use of TIL in the treatment of humans with advanced cancer.Keywords
This publication has 8 references indexed in Scilit:
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor ImmunotherapyAdvances in Cancer Research, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.The Journal of Experimental Medicine, 1980
- Passive Immunotherapy of Cancer in Animals and ManAdvances in Cancer Research, 1977
- MODELS FOR SYNGENEIC ADOPTIVE CHEMOIMMUNOTHERAPY OF MURINE LEUKEMIAS*Annals of the New York Academy of Sciences, 1976
- Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donorsInternational Journal of Cancer, 1972
- A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorshipBiometrika, 1970